Page last updated: 2024-09-03

imatinib mesylate and Liver Failure, Acute

imatinib mesylate has been researched along with Liver Failure, Acute in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (55.56)	29.6817
2010's	4 (44.44)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andraus, W; D'Albuquerque, LC; Lima, FR; Nacif, LS; Pinheiro, RS; Rocha-Santos, V; Waisberg, DR	1
Ko, AH; Simko, JP; Walker, EJ	1
Adams, L; de Boer, B; Harding, DJ; Howman, R; Jeffrey, G; MacQuillan, G; Mitchell, A	1
Funke, V; Hamerschlak, N; Neto, BH; Perini, GF; Ruiz, J; Santos, FP	1
de la Peña Moral, JM; Martínez Pascual, C; Miras López, M; Valdés Mas, M	1
Bagot, C; Cross, TJ; Gillett, D; Portmann, B; Wendon, J	1
Cacchione, R; Gadano, AC; Mandó, OG; Marciano, S; Ridruejo, E; Villamil, AG	1
Chow, WC; Chuah, TH; Lui, HF; Tan, HH; Thia, TJ	1
Bhide, M; Crispe, IN; Murthy, N; Pierce, RH; Yang, SC	1

Reviews

1 review(s) available for imatinib mesylate and Liver Failure, Acute

Article	Year
Imatinib-induced fulminant liver failure in chronic myeloid leukemia: role of liver transplant and second-generation tyrosine kinase inhibitors: a case report. Journal of medical case reports, 2018, Mar-10, Volume: 12, Issue:1 Topics: Abdominal Pain; Adult; Chemical and Drug Induced Liver Injury; Female; Humans; Imatinib Mesylate; Immunosuppression Therapy; Jaundice; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Failure, Acute; Liver Transplantation; Nausea; Protein Kinase Inhibitors; Time Factors; Treatment Outcome	2018

Article

Year

Imatinib-induced fulminant liver failure in chronic myeloid leukemia: role of liver transplant and second-generation tyrosine kinase inhibitors: a case report.

Journal of medical case reports, 2018, Mar-10, Volume: 12, Issue:1

Topics: Abdominal Pain; Adult; Chemical and Drug Induced Liver Injury; Female; Humans; Imatinib Mesylate; Immunosuppression Therapy; Jaundice; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Failure, Acute; Liver Transplantation; Nausea; Protein Kinase Inhibitors; Time Factors; Treatment Outcome

2018

Other Studies

8 other study(ies) available for imatinib mesylate and Liver Failure, Acute

Article	Year
Hepatitis B viral reactivation secondary to imatinib treatment in a patient with gastrointestinal stromal tumor. Anticancer research, 2014, Volume: 34, Issue:7 Topics: Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hepatitis B virus; Humans; Imatinib Mesylate; Liver Failure, Acute; Liver Transplantation; Male; Middle Aged; Piperazines; Pyrimidines; Virus Activation	2014
Successful Use of Dasatinib After Liver Transplantation for Imatinib-Induced Fulminant Liver Failure in Chronic Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Apr-10, Volume: 34, Issue:11 Topics: Adult; Antineoplastic Agents; Dasatinib; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Failure, Acute; Liver Transplantation; Protein Kinase Inhibitors; Treatment Outcome	2016
Nilotinib post-liver transplantation for acute hepatic failure related to imatinib. Leukemia research, 2009, Volume: 33, Issue:12 Topics: Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Failure, Acute; Liver Transplantation; Middle Aged; Piperazines; Pyrimidines	2009
[Fulminating hepatitis for imatinib in a patient with chronic myeloid leukaemia]. Medicina clinica, 2011, Sep-17, Volume: 137, Issue:7 Topics: Adult; Antineoplastic Agents; Benzamides; Chemical and Drug Induced Liver Injury; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Failure, Acute; Liver Transplantation; Piperazines; Protein Kinase Inhibitors; Pyrimidines	2011
Imatinib mesylate as a cause of acute liver failure. American journal of hematology, 2006, Volume: 81, Issue:3 Topics: Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Failure, Acute; Liver Transplantation; Middle Aged; Necrosis; Piperazines; Pyrimidines	2006
Imatinib-induced fatal acute liver failure. World journal of gastroenterology, 2007, Dec-28, Volume: 13, Issue:48 Topics: Acetaminophen; Analgesics, Non-Narcotic; Antineoplastic Agents; Benzamides; Fatal Outcome; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Failure, Acute; Middle Aged; Pain; Piperazines; Pyrimidines	2007
Imatinib mesylate-related fatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection. Singapore medical journal, 2008, Volume: 49, Issue:3 Topics: Antineoplastic Agents; Benzamides; Fatal Outcome; Hepatitis B, Chronic; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Failure, Acute; Male; Middle Aged; Piperazines; Pyrimidines	2008
Polyketal copolymers: a new acid-sensitive delivery vehicle for treating acute inflammatory diseases. Bioconjugate chemistry, 2008, Volume: 19, Issue:6 Topics: Animals; Benzamides; Drug Carriers; Hydrogen-Ion Concentration; Hydrolysis; Imatinib Mesylate; Inflammation; Kinetics; Liver Failure, Acute; Macrophages; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Particle Size; Phagosomes; Piperazines; Polymers; Pyrimidines; Solvents; Treatment Outcome	2008